Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250861
Status:
TERMINATED
Last Update Posted:
2008-04-21
First Post:
2005-11-07
Brief Title:
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin IL-2 vs Rituximab Alone for Non-Hodgkins Lymphoma
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Hodgkins Lymphoma |
Keywords: